Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13509-13-2

Post Buying Request

13509-13-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13509-13-2 Usage

General Description

2-Pyridinecarboxylic acid, 4-methyl-, methyl ester (9CI) is a chemical compound with the molecular formula C8H9NO2. It is a methyl ester derivative of 4-methyl-2-pyridinecarboxylic acid and belongs to the class of pyridinecarboxylic acids. 2-Pyridinecarboxylicacid,4-methyl-,methylester(9CI) is commonly used in the production of pharmaceuticals and agrochemicals. It has also been studied for its potential biological activities, including its anti-inflammatory and antioxidant properties. Additionally, it is used as a building block in the synthesis of various organic compounds. This chemical compound is important in the field of organic chemistry and has a wide range of applications in the pharmaceutical and agricultural industries.

Check Digit Verification of cas no

The CAS Registry Mumber 13509-13-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,5,0 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 13509-13:
(7*1)+(6*3)+(5*5)+(4*0)+(3*9)+(2*1)+(1*3)=82
82 % 10 = 2
So 13509-13-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO2/c1-6-3-4-9-7(5-6)8(10)11-2/h3-5H,1-2H3

13509-13-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 4-methylpicolinate

1.2 Other means of identification

Product number -
Other names methyl 4-methylpyridine-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13509-13-2 SDS

13509-13-2Relevant articles and documents

Synthesis of Esters by Functionalisation of CO2

-

Paragraph 0129, (2017/09/06)

The invention relates to a method for (I) producing a carboxylic ester of formula (I). Said method comprises the steps of: a) bringing an organosilane/borane of formula Si or B into contact with CO2, in the presence of a catalyst and an electrophilic compound of formula (III), the groups R1, R2, R3, R4, R5, Y, and M′ being as defined in claim 1; and optionally b) recovering the compound of formula (I) produced.

Development of an iron(II)-catalyzed aerobic catechol cleavage and biomimetic synthesis of betanidin

Guimond, Nicolas,Mayer, Peter,Trauner, Dirk

supporting information, p. 9519 - 9523 (2014/08/18)

An aerobic iron(II)-catalyzed cleavage of catechols was developed. This reaction allows for the preparation of 2-methoxy-2H-pyrans that can be employed as versatile building blocks for synthesis. The utility of this biomimetic oxidative cleavage is featured in the synthesis of betanidin, a natural colorant with antioxidant properties. Cut and paste: An aerobic iron(II)-catalyzed oxidative cleavage of catechol was developed. This reaction allows the preparation of 2H-pyrans that can be employed as versatile building blocks for synthesis. The utility of this biomimetic cleavage is featured in the synthesis of betanidin, the aglycone of red beets' principal colorant and itself a valuable antioxidant (see scheme).

1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof

-

, (2010/02/06)

Certain 1-(aromatic- or heteroaromatic-substituted-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13509-13-2